Cargando…

Long-term SARS-CoV-2 RNA Shedding and its Temporal Association to IgG Seropositivity

Mostrar otras versiones (1)

Analysis of 851 COVID-19 patients with a SARS-CoV-2-positive PCR at follow-up shows 99 patients remained SARS-CoV-2-positive after four weeks from initial diagnosis. Surprisingly, a majority of these long-term viral RNA shedders were not hospitalized (61 of 99), with variable PCR Crossing point valu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Agarwal, Vineet, Venkatakrishnan, AJ, Puranik, Arjun, Kirkup, Christian, Lopez-Marquez, Agustin, Challener, Douglas W., O’Horo, John C., Binnicker, Matthew J., Kremers, Walter K., Faubion, William A., Badley, Andrew D., Williams, Amy W., Gores, Gregory J., Halamka, John D., Morice, William G., Soundararajan, Venky
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7302207/ https://www.ncbi.nlm.nih.gov/pubmed/32577666 http://dx.doi.org/10.1101/2020.06.02.20120774

Ejemplares similares

Long-term SARS-CoV-2 RNA shedding and its temporal association to IgG seropositivity
por: Agarwal, Vineet, et al.
Publicado: (2020)

Plasma IL-6 levels following corticosteroid therapy as an indicator of ICU length of stay in critically ill COVID-19 patients
por: Awasthi, Samir, et al.
Publicado: (2021)

Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients
por: Pawlowski, Colin, et al.
Publicado: (2021)

Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations
por: Pawlowski, Colin, et al.
Publicado: (2021)

Anemia during SARS-CoV-2 infection is associated with rehospitalization after viral clearance
por: Lenehan, Patrick J., et al.
Publicado: (2021)

FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system
por: Pawlowski, Colin, et al.
Publicado: (2021)

Pre-existing conditions are associated with COVID-19 patients’ hospitalization, despite confirmed clearance of SARS-CoV-2 virus
por: Pawlowski, Colin, et al.
Publicado: (2021)

Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC)
por: Pawlowski, Colin, et al.
Publicado: (2020)

Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence
por: Puranik, Arjun, et al.
Publicado: (2021)

Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System
por: Pawlowski, Colin, et al.
Publicado: (2021)

Durability analysis of the highly effective mRNA-1273 vaccine against COVID-19
por: Puranik, Arjun, et al.
Publicado: (2022)

Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection
por: Puranik, Arjun, et al.
Publicado: (2022)

Mapping each pre-existing condition’s association to short-term and long-term COVID-19 complications
por: Venkatakrishnan, A. J., et al.
Publicado: (2021)

Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis
por: Wagner, Tyler, et al.
Publicado: (2020)

Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection
por: Niesen, Michiel J M, et al.
Publicado: (2022)

SARS-CoV-2 strategically mimics proteolytic activation of human ENaC
por: Anand, Praveen, et al.
Publicado: (2020)

Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines
por: McMurry, Reid, et al.
Publicado: (2021)

SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes
por: Pawlowski, Colin, et al.
Publicado: (2022)

Durability analysis of the highly effective BNT162b2 vaccine against COVID-19
por: Puranik, Arjun, et al.
Publicado: (2022)

Surveillance of Safety of 3 Doses of COVID-19 mRNA Vaccination Using Electronic Health Records
por: Niesen, Michiel J. M., et al.
Publicado: (2022)

Vaccination Safety: Don’t Toss the Champagne With the Cork
por: Shah, Aditya, et al.
Publicado: (2021)

Healthcare disparities among anticoagulation therapies for severe COVID‐19 patients in the multi‐site VIRUS registry
por: Kirkup, Christian, et al.
Publicado: (2021)

Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19
por: Corchado-Garcia, Juan, et al.
Publicado: (2021)

Low Utility of Repeat Real-Time PCR Testing for SARS-CoV-2 in Clinical Specimens
por: Challener, Douglas W., et al.
Publicado: (2020)

Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19
por: Corsini Campioli, Cristina, et al.
Publicado: (2020)

In Reply—Repeated Testing in SARS-CoV-2 Infection
por: Shah, Aditya, et al.
Publicado: (2020)

Diagnostic Stewardship: An Essential Element in a Rapidly Evolving COVID-19 Pandemic
por: Shah, Aditya S., et al.
Publicado: (2020)

Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants
por: Venkatakrishnan, A. J., et al.
Publicado: (2023)

Building a best-in-class automated de-identification tool for electronic health records through ensemble learning
por: Murugadoss, Karthik, et al.
Publicado: (2021)

1340. The Effect of Continuous Renal Replacement Therapy on Body Temperature in Patients with and without Infection
por: Challener, Douglas W, et al.
Publicado: (2019)

Analytics and Prediction Modeling During the COVID-19 Pandemic
por: Challener, Douglas W., et al.
Publicado: (2020)

Infectious disease physician characteristics and prescription of meropenem in the hospital
por: Challener, Douglas, et al.
Publicado: (2023)

In reply—Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research
por: O’Horo, John C., et al.
Publicado: (2021)

Initial SARS-CoV-2 PCR crossing point does not predict hospitalization and duration of PCR positivity
por: Eberly, Allison R., et al.
Publicado: (2021)

Benchmarking evolutionary tinkering underlying human–viral molecular mimicry shows multiple host pulmonary–arterial peptides mimicked by SARS-CoV-2
por: Venkatakrishnan, A. J., et al.
Publicado: (2020)

A Blueprint to Control the SARS-CoV-2 Pandemic
por: O’Horo, John C., et al.
Publicado: (2021)

Association Between Chronic Statin Use and 30-Day Mortality in Hospitalized Patients With COVID-19
por: Yetmar, Zachary A., et al.
Publicado: (2021)

Nasopharyngeal SARS-CoV-2 viral RNA shedding in patients with diabetes mellitus
por: Cano, Edison, et al.
Publicado: (2020)

Screening for COVID-19: Patient factors predicting positive PCR test
por: Challener, Douglas W., et al.
Publicado: (2020)

Community-Based Drive-Through and Walk-Through Testing Centers
por: Tande, Aaron J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k31t9dq85i9oat2i1blmr8pb8j